Studies carried out by The Pirbright Institute and the University of Oxford have shown that Oxford’s new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this...
Flu vaccine research undertaken by scientists at The Pirbright Institute has demonstrated that combining two different routes of administering flu vaccine provides pigs with better protection against disease than using only one method. The findings could inform vaccination strategies for human flu...
Pirbright is to take a lead role in a new national research project to study the effects of emerging mutations in SARS-CoV-2 . The ‘G2P-UK’ National Virology Consortium with £2.5 million of funding from UK Research and Innovation (UKRI) will study how mutations in the virus affect key outcomes such...
Severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), the virus that causes COVID-19, is thought to have originated in bats, but how it jumped hosts to infect humans is unclear, as is the potential for the virus to infect other animal species. Researchers from The Pirbright Institute have...
Prof Sir Dave Stuart, the Director of Life Sciences at Diamond Light Source and MRC Professor of Structural Biology at the University of Oxford, and Head of the Division of Structural Biology at the Department of Clinical Medicine, has been awarded a Knighthood for his years of work in structural...
Pirbright's longstanding expertise in viral diseases is helping us to provide vital services and information that will help to tackle the life changing pandemic caused by COVID-19.
Our Coronavirus Hub provides an overview of how the Institute is aiding the pandemic response, including Pirbright's COVID-19 research on vaccines, understanding how the virus works, and exploring diagnostic solutions, as well as the support we are providing to the UK diagnostic effort.
We work collaboratively with stakeholders globally, including research and academic institutions, government ministries and agencies, multilateral organisations, non-government organisations (NGOs) that range from big international charities to local advocacy groups, as well as philanthropic foundations and commercial companies.
Our innovative research into viruses of farm animals and those that spread from animals to people is possible with new state-of-the-art facilities including the BBSRC National Virology and Vaccinology Centres. Find out more about our campus.
® The Pirbright Institute 2021 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.
